Articles tagged with Vaccination
A new study from the University of Illinois Chicago found that Americans are poor at identifying conspiracy theories when they personally believe in them. Despite this, the study's author argues that recognizing the prevalence of conspiracy theories can help alleviate feelings of isolation and disconnection.
A new oral vaccine for recurrent Urinary Tract Infections (UTIs) has been shown to prevent infections in over half of participants for up to nine years. The MV140 vaccine was found to be safe and effective, with no notable side effects reported.
A Swedish study reveals that neutralising antibodies to the monkeypox virus decline significantly after two doses of the MVA-BN vaccine within the first month. The findings suggest that a booster dose may be necessary to maintain immunity, emphasizing the need for scientific evidence before policy decisions are made.
A new study finds that BCG vaccination reduces TB transmission in cattle by almost 90%. Vaccinated cows also develop significantly fewer visible signs of TB than unvaccinated ones. The vaccine has the potential to control bovine tuberculosis and put herds on a pathway towards elimination.
A new vaccine developed by UCLA researchers demonstrates high protection against melioidosis, a tropical disease that causes 89,000 fatalities annually. The vaccine was tested in mice and found effective even against a highly lethal strain of the bacteria.
A new study suggests that removing barriers to cervical cancer screening, surveillance, and diagnostic procedures can save lives and reduce disparities. If every eligible person gets the full screening and follow-up tests recommended, up to 23% fewer people would be diagnosed with cervical cancer and 20% fewer would die from it.
A competition among researchers predicted B. pertussis vaccine responses based on a simple correlation between calendar age and antibody responses. The result highlights the need for further research to understand variability in vaccination outcomes.
A new study finds that the high burden of typhoid fever in sub-Saharan African countries calls for stronger prevention strategies, including the use and implementation of typhoid conjugate vaccines. The study estimates that there are 12.5 to 16.3 million cases of typhoid every year with 140,000 deaths.
A study by Texas A&M University found that only 9% of older Americans had been vaccinated against RSV prior to this fall and winter. The study also revealed that men were more likely to be vaccinated than women, and those who were vaccinated had higher levels of concern about the disease.
Researchers found that vaccines injected into mouse eyes can disable the herpes virus and activate an immune response through lymphatic vessels along the optic nerve. This discovery highlights a shared immune response between the brain and eyes, providing a potential new approach to combating ocular and central nervous system diseases.
Researchers propose renaming VAERS as the Vaccine Safety Sentinel to reduce misinformation, citing a lack of public understanding of the system's unverified reports. They also recommend improving the system with raw data and expanded public education.
Researchers identify five grand challenges in biomedical engineering to address social needs, existing gaps, and technological limitations. The Convergence Revolution and Fourth Industrial Revolution are expected to shape the future of medicine, emphasizing interdisciplinary collaborations and next-generation training.
A study by UC Davis Health found that a single dose of BCG reduced liver tumor burden and extended the survival of mice with liver cancer. The vaccine boosted the body's immunity, leading to tumor shrinkage and improved liver function.
The VPNVax platform utilizes a modular approach to create viromimetic polymer nanoparticle vaccines with enhanced surface valence, demonstrating improved immune stimulatory effects. The research offers new insights into designing the next generation of VLP vaccines with increased durability and versatility.
A new mobile phone-based facial recognition application for dogs has been developed to improve rabies vaccination efforts in endemic areas. The app was tested at a clinic in rural Tanzania and proved remarkably accurate, identifying 76.2% of vaccinated dogs and 98.9% of unvaccinated dogs.
A subset of CD4+ 'helper' T cells helps fight cytomegalovirus infection and reduces the chances of transmission. The late-rising T cells expand long after the initial response has died down, gathering in high numbers in the salivary gland.
A Swedish study found that up to 7% of blood donors had a history of TBE virus infection, affecting over 160,000 people. Vaccination coverage was estimated at 8-57% across different regions.
Researchers from Binghamton University are unraveling the workings of Group B Strep (GBS) infections, which could someday lead to a vaccine. They have identified a novel protein that could serve as a vaccine candidate to fight this bacterium, impacting women's reproductive health and neonatal outcomes.
Researchers have found that the BCG vaccine can enhance innate immunity in individuals with dormant immune cells, predicting a positive response to vaccination. Trained immunity responders exhibited increased production of inflammatory mediators after vaccination.
Researchers have developed a novel tool for the selective and efficient recovery of large DNA molecules using TAR cloning. This technique has been applied to isolate individual gene alleles, study genome architecture and evolution, and engineer synthetic viruses with novel properties, including vaccine development.
A study found strong connections between vaccine hesitancy and support for vaccinating pets, highlighting the need for improved attitudes on vaccination rates. Pet owners with higher confidence in vaccine safety and efficacy showed lower levels of vaccine hesitancy.
A new study finds that most US parents intend to vaccinate their infants and young children against COVID-19, influenza, and respiratory syncytial virus (RSV), with 40% planning to vaccinate against COVID-19. The study also highlights the growing concern of vaccine hesitancy and its potential impact on public health.
Researchers found that a breakthrough infection builds upon existing memory B cell pool and introduces random mutations that prepare antibodies for new variants. Broad neutralizing antibodies can neutralize all tested Omicron variants.
A new study by Texas A&M University researchers found a significant decrease in measles antibody concentrations with increasing urinary arsenic levels in children with low serum folate levels. Folate intake may mitigate the toxic effects of chronic arsenic exposure, but the unequal impact of arsenic by sex remains unclear.
Research found that being overweight hampers the body's immune response to SARS-CoV-2 infection, leading to reduced antibody levels and activity. However, vaccination offered protection against COVID-19. The study suggests personalized recommendations for overweight individuals to ensure better COVID-19 management.
A new vaccine patch has delivered an effective immune response to Zika virus in mice, providing rapid protection against the disease. The patch, which uses a high-density microarray platform, targets a specific protein crucial to the virus's survival and evokes T-cell responses up to 270% higher than traditional vaccines.
A study will examine the cognitive function of older adults who were exposed to measles during childhood, shedding light on potential long-term benefits of routine childhood vaccinations. The research aims to better understand how childhood experiences shape health and well-being across the life course.
A Canadian study found that infants exposed to biologic agents during pregnancy have normal immune development and can safely receive the rotavirus vaccine. The study, involving 191 infants across six sites in Canada, aimed to change vaccination guidelines to protect more babies from severe illness.
Leading experts recommend five major factors for FDA trustworthiness, including procedural and substantive conditions, to enhance public trust in its decisions. The report aims to rebuild trust in health care and science after controversies around vaccine approvals.
Pfizer's Abrysvo vaccine was approved with conditions, including a warning about preterm birth. Experts debate whether pregnant women should have been informed about the potential risk. Some critics argue that notification would have caused unnecessary anxiety.
Bio-TCV, a typhoid conjugate vaccine developed by IVI and Bio Farma, has been licensed in Indonesia following marketing approval from BPOM. The vaccine is expected to provide protection against typhoid fever as early as 9 months of age.
A new study published in The BMJ found that the live zoster vaccine continues to provide some protection against shingles and its complications ten years after vaccination. The study analyzed data from over 1.5 million adults aged 50 and older, revealing a decline in vaccine effectiveness over time.
The UK has launched four new research hubs to address challenges of vaccine manufacturing and delivery in developing countries. The hubs will use lessons from the global COVID-19 rollout to improve processes, with funding from £33 million UK aid and £1.5 million EPSRC co-funding.
The team created a glycoengineering platform that simplifies the production of customized sugar carbohydrates, known as glycans, which play a crucial role in various therapeutic applications. This innovation enables the engineering of new glycans with unprecedented flexibility, addressing limitations in existing approaches.
A recent study by Finnish Institute for Health and Welfare reveals that the two-dose varicella vaccination programme significantly reduced health centre appointments related to chickenpox among children under 12. The number of cases decreased by more than 95% in 2022 compared to pre-vaccination levels.
A primary mRNA vaccine series offers significant protection against SARS-CoV-2 infection in Singaporean children aged 1-4. The study found a low incidence of hospitalization and severe illness, but highlights the potential benefits of vaccination in preventing infection and sequelae.
Pregnant women are urged to get vaccinated against COVID-19 to protect themselves and their babies. A new study suggests that COVID-19 vaccines and boosters can significantly improve maternal-fetal outcomes.
A study by University of Tsukuba found that elderly patients receiving better services from their primary care providers are more likely to receive the varicella-zoster virus vaccination. The study suggests that providing adequate services needed by patients during primary care may improve shingles vaccine coverage.
A new study published in Virology Journal confirms 25 different types of HPV prevalent in Nigeria, highlighting the need for region-specific vaccines. The discovery underscores the limitations of existing vaccines like Gardasil-9, which only protects against nine cancer-causing types.
A study of over 15,000 individuals with chronic kidney disease found that young age, Black race, and low education and income were linked to lower flu vaccine uptake. The study suggests that targeted vaccination efforts could improve uptake among those with kidney disease.
Researchers at George Washington University found that Facebook's core design features undermine its policies aimed at removing Covid-19 vaccine misinformation. The platform's architecture, designed to build communities around shared interests, can inadvertently facilitate the spread of misinformation.
Researchers found that hepatitis C treatment improved response to hepatitis B vaccine in individuals who previously didn't respond. The study recommends checking for hepatitis B immune protection and offering vaccination after treatment.
A study published in eBioMedicine identified the mechanism behind rapid vaccine waning in patients on TNF-α blockers for autoimmune diseases like Crohn's and rheumatoid arthritis. Regular booster vaccinations are crucial to maintain protection, especially for those receiving immunosuppressive therapy.
A new study found that voluntary collective isolation was unlikely to prevent rapid spread of COVID-19 among the Tsimané, a small-scale Indigenous society in remote Amazonia. The simulation predicted nearly identical rates of infection in real-world data, highlighting the need for targeted interventions and medical resources
Researchers found that sequential vaccinations given in the same arm generated a stronger immune response than those administered in different arms. This is particularly true for cytotoxic CD8+ T cells and antibodies targeting the SARS-CoV-2 virus.
A community-based health program implemented in Madagascar increased vaccination rates in the country's most remote villages. The study found that households with a Catholic or Protestant affiliation were more reluctant to vaccinate their children, highlighting the need to address these barriers in future programs.
A new study by the Annenberg Public Policy Center found that people are more likely to recommend an RSV vaccine if they understand the rigorous process of the FDA's vaccine approval process. The study showed that 57% of those exposed to a flowchart were very or somewhat likely to recommend the vaccine, compared to 40% in a control group.
QUT researchers have created a booster vaccine using implant technology to protect wild koalas from Chlamydia disease. The new device allows for in-the-field vaccination without recapturing the animals, reducing human interference and increasing vaccination efficiency.
A study found COVID-19 vaccination coverage was high among healthcare workers and older adults, but low among non-priority recipients. The main reason for wanting to be vaccinated was to prevent self-infection and protect family members.
Researchers created a flexible and potent 'on-demand' whole tumor cell vaccine (TCV) that responds to near-infrared laser irradiation, boosting the immune response and effectively suppressing tumor growth. The TCV was tested in various murine xenograft models and showed promising therapeutic efficacy.
A survey of over 20,000 respondents in Japan found that 23% of male and 13% of female respondents were willing to receive the smallpox vaccine for Mpox prevention. Higher vaccination rates were observed among homosexual men compared to their heterosexual counterparts.
Scientists at the University of Pittsburgh Center for Vaccine Research have identified a protein responsible for lethal liver disease in mice infected with Rift Valley fever virus. Removing this protein, Lrp1, from the liver prevented viral replication and extended mouse lifespan.
A study suggests that bare minimum reimbursement rates could be a barrier to HPV vaccination, with non-pediatric specialties receiving lower rates. Family medicine doctors were found to be most sensitive to changes in reimbursement, which may contribute to geographic disparities in vaccination rates.
A study found that family medicine physicians have the lowest net returns per dose for HPV vaccines, while pediatricians received higher reimbursement amounts. The researchers also observed a positive association between reimbursement and increased HPV vaccine doses administered, particularly among family physicians.
Two vaccines to protect against RSV are now available for those over age 60, providing high levels of protections against the virus. The vaccines were developed by Glaxo SmithKline and Pfizer and have been approved by the US Food and Drug Administration.
A new combination treatment of GVAX vaccine, nivolumab, and urelemab has shown to increase the amount of cancer-killing immune cells in tumors and appear effective when given two weeks prior to surgery. The study found a median disease-free survival of 33.51 months and a median overall survival of 35.5 months.
A UCLA-led team is tracking mpox outbreaks across the US with a new surveillance project called CRASHED. The research aims to identify cases beyond high-risk groups and determine if mpox remains rare or resurges more broadly.
A University of Queensland developed vaccine will protect farmed saltwater crocodiles from West Nile virus (WNV), providing economic benefits worth $10million per year. The vaccine is the first of its kind to achieve proven safety and efficacy in crocodiles, with a robust immune response induced after two doses.
CHOP researchers have developed stable, universal MHC-I molecules that can be produced rapidly at scale, allowing for the development of effective and universal immunotherapies. These engineered MHC-I molecules promote peptide exchange across multiple HLA allotypes, covering various forms.
A phase 3 trial found that the VLA1553 vaccine candidate produced an immune response in 99% of participants, inducing protection against disease. The study also showed that the vaccine was generally safe and well-tolerated across all age groups, with most adverse events being mild or moderate.